Hypofractionated postmastectomy radiation therapy (PMRT) delivered over three weeks is noninferior to a conventional five-week course for women undergoing breast reconstruction, according to findings published October 12 in the Journal of Clinical Oncology. A study led by Matthew M. Poppe, MD, of the Huntsman Cancer Institute at the University of Utah, found that complication rates at 24 months were 12.3% for the shorter course and 10.2% for the standard schedule, Medscape reported.
Noninferiority Results in Clinical Trial
The randomized trial enrolled 898 patients between February 2018 and August 2021 across 209 sites in the U.S. and Canada. Researchers compared 16 fractions of radiation (42.56 Gy) over three weeks against the conventional 25-fraction regimen (50 Gy) over five weeks. Among the 825 patients evaluable for the primary end point, there was no statistically significant difference in reconstruction complication rates, which included wound healing issues, unplanned readmissions, reoperations, capsular contracture, and reconstruction failure.
Recurrence and Toxicity Outcomes
Long-term data at a median follow-up of 3.9 years showed similar oncologic outcomes between the two groups. The 3-year locoregional recurrence-free survival rate reached 97.0% for the hypofractionated group and 96.2% for the conventional group. Cumulative incidence of locoregional recurrence at 3 years was 1.5% and 2.2%, respectively. Researchers also monitored non-reconstruction radiation toxicity and found no significant differences between the two treatment durations.
Reconstruction Timing and Complication Factors
Multivariable analysis revealed that the timing of reconstruction significantly influenced complication risks. Patients who underwent delayed reconstruction faced nearly triple the odds of experiencing complications compared to those who had immediate reconstruction, with an odds ratio of 2.96. While implant-only reconstructions showed numerically higher complication odds than autologous tissue procedures, the difference was not statistically significant.
Trial Limitations and Design
The study was designed with a noninferiority margin of 10%, based on an assumed 2-year complication rate of 25%. In practice, the observed complication rates were significantly lower than the initial assumptions, which authors noted did not undermine the finding of noninferiority. The trial excluded patients with T4 or N3 disease, positive margins, and those receiving proton radiotherapy, meaning the findings may not apply to these specific patient populations.
Common Questions Regarding Radiation Schedules
Does a shorter radiation course increase the risk of reconstruction failure?
The study found no statistically significant difference in reconstruction failure rates between the two groups. While complete reconstruction failure was numerically higher at 1.7% in the 16-fraction group compared to 0.7% in the 25-fraction group, the overall clinical outcomes demonstrated noninferiority.
How does reconstruction type affect recovery after radiation?
The trial data indicated that delayed reconstruction was associated with higher odds of complications compared to immediate reconstruction. Additionally, researchers observed that implant-only reconstructions had numerically higher odds of complications than autologous tissue reconstructions, though this specific comparison did not reach statistical significance.
Are these results applicable to all breast cancer patients?
The trial specifically targeted women with unilateral invasive breast cancer requiring PMRT and reconstruction. Because the study excluded patients with more advanced disease (T4 or N3), positive margins, or those receiving proton therapy, the authors noted that the findings should be interpreted with caution when applied to those specific groups.
Keep reading